Intensive-care unit and lung physician Dr. Vin Gupta advised CNBC that he is already encouraging sufferers who acquired the single-shot Johnson & Johnson Covid vaccine to get a Pfizer or Moderna booster shot amid the dramatic increase in delta variant cases throughout the U.S.
Gupta, a professor on the University of Washington’s Institute for Health Metrics and Evaluation, advised “The News with Shepard Smith” that “AstraZeneca, when combined with a Pfizer or Moderna booster, is showing tremendous levels of protection against delta, in terms of the antibody levels that are generated in patients.”
“I do think that those one-shot J&Jer’s should be given the opportunity, while we complete our clinical trial … I’m already telling my patients to do it, if they can get access to it.”
Gupta’s feedback come on the heels of a new study from a lab at New York University Tuesday that raises severe questions concerning the effectiveness of J&J’s single-dose vaccine towards the extremely contagious delta variant. The NYU examine isn’t but peer reviewed, however discovered that the antibody ranges in those that acquired the J&J shot could also be low sufficient to be much less protecting.
CNBC correspondent Meg Tirrell interviewed the lead writer of the examine, Dr. Ned Landau, who advised her that the examine suggests, “one should at least consider a second vaccination, a second shot” with the J&J vaccine, both of the identical vaccine, or one from Pfizer or Moderna.
J&J advised CNBC that its personal knowledge confirmed the vaccine “generated strong, persistent activity against the delta variant and other highly prevalent variants.”
The Centers for Disease Control and Prevention advised CNBC that it stands by its statement earlier this month about boosters that “Americans who have been fully vaccinated do not need a booster at this time.”
Gupta furthered the case for administering a booster shot when he advised host Shepard Smith that his “definition of fully vaccinated is two doses of a vaccine.”
Smith requested for clarification on whether or not Gupta considers the almost 13 million Americans who acquired the J&J dose had been really absolutely vaccinated.
“I think you’re protected, likely from the hospital and severe outcomes from say, the delta variant, based on what data we do have,” Gupta mentioned. “I do not think you have the same level of protection to transmit the virus than somebody who received two doses of the vaccine like Pfizer or Moderna. I think that is pretty clear at this point.”